Alpha Teknova (NASDAQ:TKNO) CEO Purchases $55,900.00 in Stock

Alpha Teknova, Inc. (NASDAQ:TKNO) CEO Stephen Gunstream bought 26,000 shares of the business’s stock in a transaction on Friday, March 6th. The stock was purchased at an average price of $2.15 per share, for a total transaction of $55,900.00. Following the completion of the acquisition, the chief executive officer owned 269,497 shares of the company’s stock, valued at approximately $579,418.55. This trade represents a 10.68% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Alpha Teknova Trading Up 5.0%

Shares of NASDAQ TKNO opened at $2.71 on Thursday. Alpha Teknova, Inc. has a twelve month low of $1.91 and a twelve month high of $7.48. The stock has a market cap of $145.22 million, a price-to-earnings ratio of -8.21 and a beta of 0.39. The company has a quick ratio of 3.64, a current ratio of 4.58 and a debt-to-equity ratio of 0.19. The company’s fifty day moving average is $2.82 and its 200-day moving average is $4.12.

Alpha Teknova (NASDAQ:TKNO) last released its quarterly earnings data on Thursday, February 26th. The company reported ($0.09) EPS for the quarter, meeting analysts’ consensus estimates of ($0.09). The business had revenue of $9.98 million during the quarter, compared to analysts’ expectations of $9.62 million. Alpha Teknova had a negative net margin of 42.59% and a negative return on equity of 23.32%. Equities research analysts predict that Alpha Teknova, Inc. will post -0.58 EPS for the current year.

Institutional Trading of Alpha Teknova

Institutional investors have recently modified their holdings of the company. XTX Topco Ltd acquired a new position in shares of Alpha Teknova during the fourth quarter worth about $77,000. Marshall Wace LLP lifted its stake in Alpha Teknova by 286.1% in the 4th quarter. Marshall Wace LLP now owns 50,156 shares of the company’s stock valued at $191,000 after acquiring an additional 37,164 shares in the last quarter. Jane Street Group LLC bought a new stake in Alpha Teknova in the 4th quarter valued at approximately $239,000. T3 Companies LLC acquired a new position in Alpha Teknova during the 4th quarter worth approximately $124,000. Finally, Royce & Associates LP bought a new position in shares of Alpha Teknova during the 4th quarter worth approximately $1,116,000. 13.81% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on TKNO. Zacks Research raised Alpha Teknova to a “hold” rating in a research note on Wednesday, December 10th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Alpha Teknova in a report on Wednesday, January 21st. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Alpha Teknova presently has an average rating of “Hold” and a consensus target price of $8.00.

About Alpha Teknova

Alpha Teknova, Inc (NASDAQ: TKNO) is a life science tools and reagents company that develops, manufactures and distributes proprietary products to support research, drug discovery and biomanufacturing. Its offerings target academic institutions, pharmaceutical and biotechnology firms, and diagnostic developers, with a focus on high-purity reagents and optimized workflows designed to accelerate molecular biology and protein science applications.

The company’s portfolio includes molecular biology reagents, cell culture buffers, in vitro translation kits, custom recombinant proteins, high-throughput screening buffers and other specialized formulations.